Impact of renal failure on the risk of myocardial infarction and death

Srinivasan Beddhu1, Kristina Allen-Brady, Alfred K Cheung

  • 1Renal Section, Salt Lake VA Healthcare System, Salt Lake City, Utah, USA. Srinivasan.beddhu@hsc.utah.edu

Kidney International
|October 10, 2002
PubMed

Insights

Renal failure significantly increases the risk of myocardial infarction and death, even at moderate stages. This risk is independent of other known cardiovascular disease factors and treatments.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • High cardiovascular morbidity and mortality are observed in patients with renal failure.
  • It remains unclear if pre-existing cardiovascular disease or the uremic state itself drives this increased risk.

Purpose of the Study:

  • To determine if renal failure independently elevates the risk of myocardial infarction and death.

Main Methods:

  • The Intermountain Heart Study included 8600 patients undergoing coronary angiography.
  • Glomerular filtration rate (GFR) was calculated using the Modification of Diet in Renal Disease formula.
  • Cox regression models analyzed the association between GFR and outcomes like myocardial infarction and death.

Main Results:

  • Patients in the lowest GFR quartile (mean GFR 41 mL/min) faced significantly higher risks.
  • Adjusted analyses showed increased risk for myocardial infarction (RR 1.51) and death (RR 2.60) in the lowest GFR quartile.
  • These associations persisted even after accounting for coronary disease severity and treatment.

Conclusions:

  • Moderate renal failure independently elevates the risk of myocardial infarction and death.
  • This increased risk is evident irrespective of clinical variables, baseline coronary disease, or therapy.
  • Findings highlight the critical role of kidney function in cardiovascular outcomes.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...